ArticleCancer cell international2023

Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes.

Kewei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.